(4aR,6aS,7R,9aS,9bS,11aR)-Methyl 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate

CAS: 2124269-75-4

Ref. TR-M303120

Informação sobre produto

• Nome: (4aR,6aS,7R,9aS,9bS,11aR)-Methyl 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate
• Sinónimos: methyl (1R,3aS,3bS,5aR,9aR,11aS)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxylate

Descrição

Applications (4aR,6aS,7R,9aS,9bS,11aR)-Methyl 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate is a derivative of (Dutasteride) D735000, a dual inhibitor of 5α-reductase isoenzymes type 1 and 2; structurally related to Finasteride (F342000). Dutasteride is used in the treatment of benign prostatic hyperplasia.
References Bakshi, R.K., et al.: J. Med. Chem., 38, 3189 (1995); Gisleskog, P.O., et al.: Brit. J. Clin. Pharmacol., 47, 53 (1999); Djavan, B., et al.: Expert Opin. Pharmacother., 6, 311 (2005)

• Marca: TRC

Propriedades químicas

• Peso molecular: 331.449
• Fórmula: C₂₀H₂₉NO₃
• Cor/forma: Neat
• InChI: InChI=1S/C20H29NO3/c1-19-10-8-14-12(13(19)5-6-15(19)18(23)24-3)4-7-16-20(14,2)11-9-17(22)21-16/h9,11-16H,4-8,10H2,1-3H3,(H,21,22)/t12-,13-,14?,15-,16+,19-,20+/m0/s1
• Chave InChI: InChIKey=WMSQGMYJYBSBKA-JNPCSKDPSA-N
• SMILES: COC(=O)[C@@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)C3CC[C@@]21C